Application 1034
Selective internal radiation therapy (SIRT) for hepatic metastases using SIR-SpheresŪ
Application No. | 1034 |
| Application Name | Selective internal radiation therapy (SIRT) for hepatic metastases using SIR-SpheresŪ |
| Advisory Panel | Dr John Primrose (Chair and Medical Advisor to the MSAC) Mr Stephen Blamey (MSAC member) Dr David Macfarlane (Australian and New Zealand Association of Physicians in Nuclear Medicine nominee) Mr Russell McGowan (Consumers' Health Forum of Australia nominee) Professor John Zalcberg (Medical Oncology Group of Australia nominee) |
| Date Received by MSAC Secretariat | 9 May 2000 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | This assessment was considered by the MSAC at the 6 March 2002 meeting. Since there is insufficient evidence of effectiveness and cost-effectiveness for SIRT using SIR-SpheresŪ, the MSAC recommended that public funding should not be supported at this time. The data suggests that the treatment is reasonably safe and has anti-tumour activity. However, it is not clear whether this anti-tumour activity translates into a survival or quality of life benefit to the patient. |
| Stage 4 - Decision | Endorsed by the Minister for Health and Ageing 28 August 2002 |
| Stage 5 - Implementation |  |
Page currency, Latest update: 03 April, 2009
